The latest news from oncology events around the world
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given…
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…
New data from landmark analysis presented today report a decreased risk of disease recurrence or…
New data presented today reveals that the PanCan nodule management protocol demonstrates superior performance in…
The evolution of retinoblastoma treatment over the past 15 years has resulted in a higher…
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering…
The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions…
For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment…
Trastuzumab deruxtecan delays cancer growth for people with hormone receptor-positive (HR+), human epidermal growth factor…